WIF1 and cancer: Most studies elevated WIF1 levels using the common DNA demethylating agent 5-azacytidine (5-Aza) and its derivative 5-aza-20-deoxycytidine (Decitabine), which have been tested in phase I and II trials for many forms of cancer.